Crinetics Pharmaceuticals (NASDAQ:CRNX) Given New $42.00 Price Target at JMP Securities themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target cut by HC Wainwright from $35.00 to $33.00 in a research note released on Wednesday morning, MarketBeat Ratings reports. The firm currently has a buy rating on the stock. A number of other equities analysts also recently commented on CRNX. JMP Securities boosted their price […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) CEO Richard Scott Struthers sold 50,000 shares of the business’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $20.81, for a total transaction of $1,040,500.00. Following the sale, the chief executive officer now owns 680,805 shares in the company, […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating)’s share price traded down 5.5% during trading on Thursday following insider selling activity. The company traded as low as $18.58 and last traded at $18.62. 204,711 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 444,003 shares. The stock had previously […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) has received a consensus recommendation of “Buy” from the six ratings firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have issued ratings on the stock in the last […]